Skip to main content
Premium Trial:

Request an Annual Quote

Suresh Pisharody, Haley Fiske, Greg Hannon, John Quackenbush, George Church

Premium
Suresh Pisharody has joined Illumina as senior market manager for sequencing platforms. He came to Illumina about two months ago from Applied Biosystems, where he was senior product line manager for SOLiD reagents and workflow.
 
Also, Haley Fiske has become a regional account manager at Illumina. He, too, recently joined the company from Applied Biosystems, where as of March, he was director of product management for high-throughput discovery systems, working with the SOLiD platform.
 

 
Greg Hannon, along with two other investigators, has won the Memorial Sloan-Kettering Cancer Center’s 2007 Paul Marks Prize for Cancer Research. He is a professor at Cold Spring Harbor Laboratory and a Howard Hughes Medical Institute investigator. Winners receive a medal and share a cash award of $150,000. The three recipients will speak about their work at a public symposium held at Memorial Sloan-Kettering Cancer Center on Dec. 6. Hannon is a leader in RNA interference, a mechanism for regulating the expression of genes. He holds a PhD in molecular biology from Case Western Reserve University.
 

 
John Quackenbush has joined the scientific advisory board of Dermtech. He is a professor of biostatistics and computational biology at the Dana-Farber Cancer Institute and a professor of computational biology and bioinformatics at the Harvard School of Public Health. Quackenbush is also a scientific advisor of Helicos BioSciences.
 

 
George Church is chairman of the scientific advisory board of Enzymatics, an enzyme producer based in Beverly, Mass. Church, a professor of genetics at Harvard Medical School, is working with the company to reduce the cost of enzymes for the new sequencing platform his lab has developed (see Short Reads in this issue).

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.